publication date: Dec. 2, 2011
After Aggressive Budgetary Trimming, At $33 Million NCI’s caBIG Remains Big Health Canada Suspends Avastin Approval; CMS Has Taken No Action After FDA Decision Download PDF
To access this members-only content, please log in.
Institutional subscribers, please log in with your IP.
If you're not a subscriber why not join today?
To gain access to the members only content click here to subscribe.
You will be given immediate access to premium content on the site.
Click here to join.

Copyright (c) 2020 The Cancer Letter Inc.